Related Experiment Video
Updated: Aug 2, 2025

An Optimized Enrichment Technique for the Isolation of Arthrobacter Bacteriophage Species from Soil Sample Isolates
Published on: April 9, 2015
Isolation of new Klebsiella pneumoniae phage PSKP16
Sara Sadeqi1, Slawomir Michniewski2, Farhad Nikkhahi3
1Department of Medical Microbiology, Qazvin University of Medical Sciences, Qazvin, Iran.
Background And Objectives:
Klebsiella pneumoniae is a clinically relevant opportunistic pathogen belonging to the Enterobacteriaceae family. It is in the top three bacteria associated with antimicrobial resistance deaths globally, and one of the most dangerous bacteria causing nosocomial infections. Phage therapy offers a potential option for the treatment of drug-resistant bacterial infections.
Materials And Methods:
Phage PSKP16 was isolated against K. pneumoniae, capsular type K2 (isolated from a wound infection). PSKP16 is a new lytic phage with a Siphovirus-like morphology.
Results:
PSKP16 is a linear double stranded DNA phage with a GC content of 50% and genome size of 46,712 bp, for which we predicted 67 ORFs. PSKP16 belongs to the genus Webervirus and shows high evolutionary proximity to Klebsiella phages JY917, Sushi, and B1.
Conclusion:
Phage isolation is fast, cheap and efficient, but it requires time and characterization (which adds expense) to ensure that the isolated phages do not pose a health risk, which is essential to safely use phage therapy to treat life-threatening bacterial infections.
Insights
A novel lytic bacteriophage, PSKP16, was identified for treating Klebsiella pneumoniae infections. This phage offers a promising avenue for combating antimicrobial resistance, a critical global health challenge.
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- Klebsiella pneumoniae is a major cause of nosocomial infections and antimicrobial resistance deaths.
- Phage therapy presents a viable alternative for treating infections caused by drug-resistant bacteria.
Purpose of the Study:
- To isolate and characterize a bacteriophage effective against Klebsiella pneumoniae.
- To evaluate the potential of phage therapy in combating antibiotic-resistant Klebsiella pneumoniae.
Main Methods:
- Isolation of bacteriophage PSKP16 against Klebsiella pneumoniae (capsular type K2).
- Morphological and genomic characterization of the isolated phage, including genome size and GC content.
- Phylogenetic analysis to determine evolutionary proximity to other Klebsiella phages.
Main Results:
- Phage PSKP16, a lytic phage with Siphovirus-like morphology, was successfully isolated.
- PSKP16 possesses a linear double-stranded DNA genome of 46,712 bp with 67 predicted ORFs.
- The phage belongs to the Webervirus genus and is closely related to other Klebsiella phages.
Conclusions:
- Phage isolation is an efficient method for discovering novel therapeutic agents.
- Thorough characterization of isolated phages is crucial for ensuring safety in phage therapy applications.
- PSKP16 represents a potential candidate for phage therapy against Klebsiella pneumoniae infections.
Related Concept Videos
Lysogenic Cycle of Bacteriophages
Lytic Cycle of Bacteriophages
DNA Bacteriophages

